Last reviewed · How we verify

NCT06318013

Perineural and Systemic Dexamethasone Use in Dental Surgeries in Terms of Anesthesia Duration and Postop Complaints

Completed Last updated 31 May 2024
What this trial tests

trial testing vitality test in Impacted Third Molar Tooth in 60 participants. Completed in 26 May 2024.

Timeline
27 March 2024
Primary endpoint
15 April 2024
26 May 2024

Quick facts

Lead sponsorKaramanoğlu Mehmetbey University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment60
Start date27 March 2024
Primary completion15 April 2024
Estimated completion26 May 2024
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Karamanoğlu Mehmetbey University

Who can join

Adults 18 to 35, any sex, with Impacted Third Molar Tooth. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Participants will be asked to use some medications after the tooth extraction procedure. These drugs can be used in different ways. Investigators plan to monitor the pain, swelling and duration of anesthesia in the body as a result of participants use.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Comparison of perineural and systemic dexamethasone use in impacted third molar surgeries in terms of anesthesia duration and postoperative complaints: a controlled, randomized observational study.
    Kaya DI, Aktı A. · · 2024 · cited 1× · PMID 38890655 · DOI 10.1186/s12903-024-04483-4

Verify or expand the search:

Other recruiting trials for Impacted Third Molar Tooth

Currently open trials in the same condition.

Other Karamanoğlu Mehmetbey University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06318013.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing